A patient will be taking dabigatran (Pradaxa) as part of treatment for chronic atrial fibrillation.Which statements about dabigatran are true? (Select all that apply.)
A) The dose of dabigatran is reduced in patients with decreased renal function.
B) Bleeding is the most common adverse effect.
C) Potassium chloride is given as an antidote in cases of overdose.
D) Dabigatran levels are monitored by measuring prothrombin time/international normalized ratio (PT/INR) results.
E) This drug is a prodrug and becomes activated in the liver.
Correct Answer:
Verified
Q7: A patient will be receiving a thrombolytic
Q9: When administering heparin subcutaneously,the nurse will follow
Q9: A patient is being discharged on anticoagulant
Q10: A patient has been instructed to take
Q11: A patient has been prescribed warfarin (Coumadin)in
Q11: A patient who has been anticoagulated with
Q13: A patient has received an overdose of
Q14: A patient has received an overdose of
Q15: A patient is receiving heparin therapy as
Q15: A patient has had recent mechanical heart
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents